SCHEMBL26239778

SCHEMBL26239778

CCCCCc1ccc(CCCO)cc1CCCCC

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCHE P06276 1/20 0.48
CYP3A4 P08684 3/20 0.47
ESR1 P03372 2/20 0.47
ADRA2A P08913 2/20 0.47
ADORA3 P0DMS8 2/20 0.47
TACR2 P21452 2/20 0.47
SLC6A2 P23975 2/20 0.47
SLC6A4 P31645 2/20 0.47
SLC6A3 Q01959 2/20 0.47
TP53 P04637 2/20 0.47
PTGS2 P35354 2/20 0.47
KDM4E B2RXH2 1/20 0.47
ALDH1A1 P00352 1/20 0.47
LMNA P02545 1/20 0.47
SHBG P04278 1/20 0.47
HSPD1 P10809 1/20 0.47
ADRB3 P13945 1/20 0.47
HTR2C P28335 1/20 0.47
HSPE1 P61604 1/20 0.47
HIF1A Q16665 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26239795 0.98 PTGS2 (0.50) BCHECYP3A4ESR1ADRA2AADORA3
SCHEMBL26239820 0.95 BCHE (0.54) BCHECYP3A4ESR1ADRA2AADORA3
SCHEMBL8561136 0.91 CYP3A4 (0.50) CYP3A4ESR1ADRA2AADORA3TACR2
SCHEMBL26239727 0.89 TP53 (0.50) BCHECYP3A4ESR1ADRA2AADORA3
SCHEMBL26239744 0.89 TP53 (0.50) BCHECYP3A4ESR1ADRA2AADORA3
SCHEMBL9862240 0.89 PTGS2 (0.53) CYP3A4ESR1ADRA2AADORA3TACR2
SCHEMBL9862310 0.89 PTGS2 (0.53) CYP3A4ESR1ADRA2AADORA3TACR2
SCHEMBL20420632 0.89 BCHE (0.44) BCHESLC6A2SLC6A4KDM4EALDH1A1
SCHEMBL28414169 0.87 CYP3A4 (0.51) CYP3A4ESR1ADRA2AADORA3TACR2
Ethylene SCHEMBL28058316 0.87 CYP3A4 (0.47) CYP3A4ESR1ADRA2AADORA3TACR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024098361-A1 ARTIFICIAL NUCLEIC ACID MOLECULE 斯微(上海)生物科技股份有限公司 2024-05-16 WO disclosed
US-20230263742-A1 A LIPID Stemirna Therapeutics Co., Ltd. (CN) 2023-08-24 US disclosed
US-20230263742-A1 A LIPID Stemirna Therapeutics Co., Ltd. (CN) 2023-08-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230263742-A1 A LIPID CETP, PLIN1, AUP1 BCHE 3773/4885CYP3A4 3814/4885ESR1 4202/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.